Company Description
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.
The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare.
It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online.
Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022.
The company was incorporated in 2019 and is based in Salt Lake City, Utah.
| Country | United States |
| Founded | 2019 |
| IPO Date | May 31, 2024 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 65 |
| CEO | Timothy Pickett |
Contact Details
Address: 5097 South 900 East, Suite 100 Salt Lake City, Utah 84117 United States | |
| Phone | 385-388-8220 |
| Website | kindlymd.com |
Stock Details
| Ticker Symbol | KDLY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.50 |
| CIK Code | 0001946573 |
| ISIN Number | US49457M1062 |
| Employer ID | 84-3829824 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Timothy Pickett | Founder, Chief Executive Officer and Chairman |
| Jared E. Barrera M.B.A. | Chief Financial Officer |
| Adam Cox | Chief Operating Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | 8-K | Current Report |
| Oct 15, 2024 | 8-K | Current Report |
| Sep 19, 2024 | DEF 14A | Other definitive proxy statements |
| Sep 6, 2024 | PRE 14A | Other preliminary proxy statements |
| Aug 20, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 10-Q | Quarterly Report |
| Jun 27, 2024 | 10-Q | Quarterly Report |
| Jun 5, 2024 | 8-K | Current Report |